DC BioSciences

Pioneers in Proteomics
Find Out More

First Class Services from First Class Scientists

DC Biosciences provides pharmaceutical and biotech companies with novel technologies and proteomics services to accelerate the development of safer drugs. We are best placed to apply our knowledge and experience in a wide range of bioscience disciplines including quantitative proteomics, chemical biology, biochemistry, molecular biology, bioinformatics and cell biology to provide solutions in key areas of drug discovery and development

News
ADAPTED Project meeting in Edinburgh – understanding APOE

This week Francesco Rao attended a progress meeting for the ADAPTED project. For this meet up the city of choice was Edinburgh, some might argue the most beautiful city in the world! After a successful launch year, this was the first consortium meeting in 2018. With someone in the developing Dementia every 3 seconds, the importance […]

News
Through the Looking Glass: Peptide identification

In previous instalments, we looked at what happens to the poor peptides we send to their doom down the rabbit hole and into the strange wonderland that is the inside of a mass spectrometer[1]. Now, it’s all fine and good to fragment peptides into tiny little pieces, I for one am all for it. I […]

News
Follow The White Rabbit – Interpreting Individual Peaks – MS2 spectra

Hi everyone, and welcome to a glorious New Year! 2017 was fun, wasn’t it? I for one so much look forward to 2018 being slightly more normal. Oh what the hell, who am I kidding, I’ll get some popcorn already. Today, we will be talking about MS2 spectra, that is, the spectra resulting from the […]